Cyclacel stock: buy or sell?
May 13th, 2020
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases.
Should I buy Cyclacel stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Cyclacel stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Cyclacel stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for CYCCP stock for the last 30 days.
Cyclacel stock analysis
Cyclacel Pharmaceuticals plunged -7.57% to $6.47 after topping to all time highs on April 20th.
On April 20th, CYCCP hit a new all time high, pushing higher than tops. Check different trading setups that use ATHs as triggers. After boosting a dazzling 25.71% on May 7th, Cyclacel Pharmaceuticals closed on May/13 at $6.47 and plunged a frightening -7.57%. On December CYCCP price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. From a daily outlook perspective, CYCCP is drawing an uptrend of rising tops and rising bottoms. Since its last top on Apr 20th at $8.07, price slid and bounced up back from $5.20. Breaking down under $5.20 would cancel the current uptrend and it might slide further to test lower supports. Note that $8.07 might act as a resistance line. Trading the long side, we should wait to a new breakout over $8.07 to find the next buy point.
After boosting an extraordinary 25.71% in a week early May, Cyclacel Pharmaceuticals closed this week at $6.47 and plummed a spooky -7.57%.
Not so far away is the last all-time high Cyclacel marked late April, but since then it dropped a 19.83%. Cyclacel stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Early May, SMA20w and SMA40w crossed up triggering a rise of 24.42%. Since mid January when CYCCP stock price broke up the SMA40w line, it gained $1.74 (36.79%).
Cyclacel stock price history
Cyclacel IPO was on November 30th, 2005 at $1.02 per share1. Since then, CYCCP stock grew a 534.30%, with an average of 38.20% per year. If you had invested right after CYCCP's IPO a $1,000 in Cyclacel stock in 2005, it would worth $5,343.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Cyclacel stock historical price chart
CYCCP stock reached all-time highs on Apr 20th with a price of $8.07.
Cyclacel stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price prediction for Cyclacel Pharmaceuticals stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Cyclacel ownershipWhen you are planning to invest in a stock, it's worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Cyclacel Pharmaceuticals, 0.00% of all outstanding shares are owned by its staff.
In case of Cyclacel stock, 1.16% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CYCCP stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related companies:
|Market cap||$80.9 M|
|Total shares||12.5 M|
|Float shares||0.8 M|
|- Institutional holdings (%)||1.2%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Wednesday, May 13th, 2020|
|Day range||$6.47 - $7.43|
|Average true range||$0.94|
|50d mov avg||$5.05|
|100d mov avg||$5.08|
|200d mov avg||$4.64|
Cyclacel performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. In the following table, we compare Cyclacel performance to :